New pill could help women regrow hair – major trial underway
Disease control
Recruiting now
This study tests an experimental oral drug called VDPHL01 for women with mild to moderate genetic hair loss (androgenetic alopecia). About 552 women aged 18–65 will receive either the drug or a placebo for 13 months. The main goal is to see if the drug increases hair count and is…
Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC